High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Sony Music Entertainment on Monday filed a new lawsuit against AI startup Udio, alleging the company infringed on the copyrights of more than 30,000 recordings.
Most shoppers do not expect something as simple as a bakery roll to carry a safety risk. But food recalls can sometimes involve products consumers never see in their original packaging. This is especially true of products, which are shipped in bulk to grocery-store bakeries, restaurants, or other ...
Novo alleges that Lilly’s Zepbound advertisements compare the drug’s highest approved dose with lower doses of Wegovy.
Court strips shareholder case of class-action status
Arbutus Biopharma and Genevant Sciences have filed multiple patent infringement lawsuits against Pfizer and BioNTech over their mRNA-LNP COVID-19 vaccines. The new cases extend beyond the existing U.S. litigation into several international jurisdictions. The lawsuits seek monetary damages and potential injunctions on vaccine products, raising legal and operational risks for Pfizer. Pfizer, listed as NYSE:PFE, is facing an expanded legal challenge as Arbutus Biopharma and Genevant Sciences...
A new class action lawsuit alleges a coolant leak defect in certain Chevrolet, GMC, and Buick vehicles produced by General Motors (NYSE:GM). Plaintiffs claim GM knew about an engine issue tied to coolant leaks and did not adequately warn customers or fix the problem. The suit alleges violations of warranty and consumer protection laws and seeks relief on behalf of affected vehicle owners. General Motors remains a major global automaker with a portfolio that spans internal combustion...
(Bloomberg) -- Lawyers for President Donald Trump and his sprawling business interests are heading to court this week in Florida for high-stakes hearings that follow a pair of major setbacks in their wave of multibillion-dollar lawsuits.Most Read from BloombergUS Strikes Iran in Escalating Campaign After Troops KilledThousands of Trucks Haul Iraq’s Oil Through Syria in Sign of Hormuz LegacyUS Strikes Iran to ‘Punish’ It for Attack That Killed 2 TroopsTrump Silent So Far on Iran Plans as US Death
On the latest episode of Equity, we debate whether Apple's lawsuit will cast over OpenAi's much-discussed plans to get into hardware and go public.
Merck (NYSE:MRK) received FDA approval for Lipfendra (enlicitide), the first oral PCSK9 cholesterol-lowering drug. Lipfendra introduces an oral option for patients who have so far relied on injectable PCSK9 therapies. The approval expands Merck’s presence in cardiovascular medicine as key products approach patent expirations. Merck, trading around $127.5, is adding Lipfendra to its portfolio at a time when NYSE:MRK has posted a 64.8% return over the past year and 92.2% over five years. The...
A parasite outbreak tied to Taylor Farms sends Walmart and Yum Brands shares lower while Sweetgreen rallies on relief.
(Bloomberg) -- Walmart Inc. said it has removed four bagged iceberg lettuce salad products manufactured by Taylor Farms as recalls tied to a cyclosporiasis outbreak expand. Most Read from BloombergFCC Near Rulings Against Disney Over ‘The View,’ TV LicensesTaylor Farms Pulls Mexican Lettuce as Parasite Cases RiseChip Stocks Slide Into Bear Market in AI Unwind: Markets WrapSpaceX Slump Wipes Out $1 Trillion in Market Value From PeakGoogle Gemini Launch Delayed as Tech Falls Short of Internal Goal
In recent days, Lucid Group has repeatedly denied rumors that it is considering bankruptcy or going private, explaining that adviser AlixPartners is focused on operational improvements rather than restructuring and that existing liquidity is sufficient to fund operations well into next year. At the same time, multiple securities class action filings over concealed Gravity SUV delivery issues and halted guidance underscore ongoing questions about Lucid’s governance, disclosure practices, and...
By Daniel Wiessner July 17 (Reuters) - A U.S. judge on Friday rejected a bid by 26 employees of Meta Platforms to block the tech giant from laying them off while they pursue claims that they were
Investing.com -- Apple Inc. and the US Justice Department are in early discussions to settle a 2024 antitrust lawsuit, Bloomberg reported Friday.
Apple and the U.S. Department of Justice are in early discussions about settling a 2024 lawsuit that alleges the iPhone maker violated antitrust laws, Bloomberg News reported on Friday. Reuters could not immediately verify the report. (Reporting by Jaspreet Singh in Bengaluru)
(Bloomberg) -- Apple Inc. and the US Justice Department are in early discussions about settling a 2024 lawsuit that alleges the iPhone maker violated antitrust laws. Most Read from BloombergFCC Near Rulings Against Disney Over ‘The View,’ TV LicensesChip Stocks Poised for Bear Market in AI Unwind: Markets WrapGoogle Gemini Launch Delayed as Tech Falls Short of Internal GoalsChina’s Moonshot Unveils AI Model That Narrows Gap With US FirmsThailand Scraps Plan to End Visa-Free Entry for Indian Tour
NEW YORK, July 17 (Reuters) - A New York state judge dismissed a lawsuit by a former JPMorgan Chase banker who in graphic terms said his former supervisor coerced him into sex and demanded his
MSD has outpaced rivals to market the first PCSK9 inhibitor in pill form for patients with high cholesterol.
3M stock has more than doubled over the past three years, while current checks suggest the shares trade below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and also screen as undervalued on traditional earnings multiples. At the same time, a mixed broader valuation score and fresh legal action over PFAS chemicals mean the gap between price and estimated value is not a straightforward story. 3M has delivered a 103.6% return over the last three years, which puts...
There's a reason Costco will pretty much let you return any item at any time without a hassle. Costco has built its reputation on offering high-quality products at competitive prices, backed by strict supplier standards and careful product selection. The company knows its products have been ...
The daily medication is expected to be list-priced at $10.50 per pill. Here's what to know about Merck's new cholesterol drug Lipfendra.
Lipfendra, to be taken once a day, is designed to help lower cholesterol levels beyond what statins alone can achieve.
In April 2026, Intuitive Surgical voluntarily initiated an ongoing Class II worldwide recall of certain da Vinci surgical system components after discovering an E-brake retainer pin issue that could impede emergency braking or cause uncontrolled column motion, with 454 affected units identified by specific serial numbers. This safety action, alongside growing attention on Intuitive’s AI-enabled da Vinci 5 rollout and competitive pressures in robotic surgery, raises fresh questions about how...
European cloud and infrastructure groups have challenged Broadcom over recent VMware licensing changes following the acquisition. Trade association CISPE and others have asked EU antitrust regulators to review and suspend certain Broadcom practices tied to VMware contracts. The European Commission has opened an antitrust review that centers on access, pricing, and conditions for VMware software in the region. Broadcom (NasdaqGS:AVGO) is coming under closer regulatory scrutiny in Europe at a...
Apple stock has gained 121.0% over the past 5 years, yet its current valuation checks are split, with a Discounted Cash Flow (DCF) intrinsic value estimate suggesting the shares trade at a premium while earnings based multiples still screen as relatively supportive. That tension leaves investors weighing a strong long term share price record against signals that today’s price may already reflect a lot of optimism. Apple’s 121.0% return over 5 years highlights how strongly the stock has...
OpenAI’s struggles could cause the AI bubble to burst, bringing down with it much more than the company’s hardware division.
OpenAI says it sees no evidence supporting Apple's lawsuit over alleged trade-secret theft.
OpenAI plans a screen-free AI home device while Apple seeks an injunction that could delay its rollout.
OpenAI still plans a year-end device reveal, but Apple's lawsuit, ecosystem strength and rising component costs may complicate its hardware push.
Pfizer Inc. (NYSE:PFE) is one of the 8 Worst Blue Chip Stocks to Buy Now. On July 10, 2026, Pfizer Inc. (NYSE:PFE) and Astellas Pharma (ALPMY) announced that the U.S. Food and Drug Administration approved PADCEV, a Nectin-4 directed antibody-drug conjugate, plus the PD-1 inhibitor Keytruda or Keytruda QLEX as neoadjuvant and adjuvant treatment for […]
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.